| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |